These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15269783)

  • 21. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
    Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
    J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology.
    Watson VG; Drake KM; Peng Y; Napper AD
    Assay Drug Dev Technol; 2013 May; 11(4):253-68. PubMed ID: 23679849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias.
    Nakanishi H; Nakamura T; Canaani E; Croce CM
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14442-7. PubMed ID: 17726105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation.
    Joh T; Kagami Y; Yamamoto K; Segawa T; Takizawa J; Takahashi T; Ueda R; Seto M
    Oncogene; 1996 Nov; 13(9):1945-53. PubMed ID: 8934541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AF4 encodes a ubiquitous protein that in both native and MLL-AF4 fusion types localizes to subnuclear compartments.
    Li Q; Frestedt JL; Kersey JH
    Blood; 1998 Nov; 92(10):3841-7. PubMed ID: 9808577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.
    Barretto NN; Karahalios DS; You D; Hemenway CS
    J Exp Ther Oncol; 2014; 10(4):293-300. PubMed ID: 25509985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
    Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.
    Schmidt CR; Achille NJ; Kuntimaddi A; Boulton AM; Leach BI; Zhang S; Zeleznik-Le NJ; Bushweller JH
    Blood Cancer Discov; 2020 Sep; 1(2):162-177. PubMed ID: 32954361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
    Wilkinson AC; Ballabio E; Geng H; North P; Tapia M; Kerry J; Biswas D; Roeder RG; Allis CD; Melnick A; de Bruijn MF; Milne TA
    Cell Rep; 2013 Jan; 3(1):116-27. PubMed ID: 23352661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia.
    Prasad R; Yano T; Sorio C; Nakamura T; Rallapalli R; Gu Y; Leshkowitz D; Croce CM; Canaani E
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12160-4. PubMed ID: 8618864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
    Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
    Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
    Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
    Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
    Kawagoe H; Kawagoe R; Sano K
    Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.
    Lin S; Luo RT; Shrestha M; Thirman MJ; Mulloy JC
    Blood; 2017 Aug; 130(7):903-907. PubMed ID: 28637661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.
    Caslini C; Serna A; Rossi V; Introna M; Biondi A
    Leukemia; 2004 Jun; 18(6):1064-71. PubMed ID: 14990976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias.
    Strick R; Zhang Y; Emmanuel N; Strissel PL
    Hum Genet; 2006 Jun; 119(5):479-95. PubMed ID: 16572268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.
    Thomas M; Gessner A; Vornlocher HP; Hadwiger P; Greil J; Heidenreich O
    Blood; 2005 Nov; 106(10):3559-66. PubMed ID: 16046533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.
    Hinterleitner C; Huelsenbeck J; Henninger C; Wartlick F; Schorr A; Kaina B; Fritz G
    Apoptosis; 2013 Aug; 18(8):963-79. PubMed ID: 23624644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.